Company: RGNT
Filing Date: 2025-05-19
Form Type: F-1/A
Source: 0001213900-25-045479
Chunk: 293

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-19
Form: F-1/A
Chunk 293
---
 is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

(d) The undersigned registrant
hereby undertakes that:

| (1) | That for purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. |

| (2) | That for the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |

<div align='center'>II-6

EXHIBIT INDEX</div>

| EXHIBIT 
 NUMBER  |     | EXHIBIT DESCRIPTION                                                                                                                                                                                                                             |
| 1.1*    |     | Form of Underwriting Agreement                                                                                                                                                                                                                  |
| 3.1*    |     | Amended and Restated Articles of Association of the Registrant, as currently in effect                                                                                                                                                          |
| 3.2*    |     | Form of Amended and Restated Articles of Association of the Registrant to be in effect upon the consummation of this offering                                                                                                                   |
| 4.1*    |     | Form of Representative’s Warrant                                                                                                                                                                                                                |
| 4.2*    |     | Amedned and Restated Investors’ Rights Agreement, by and among Regentis Biomaterials Ltd., HaisThera Scientific Fund L.P. and the Owners and Holders of Series D-1 Preferred Shares and Series D-2 Preferred Shares, dated February 4, 2016     |
| 5.1*    |     | Opinion of Doron Tikotzky Kantor Gutman & Amit Gross, Israeli counsel to the Registrant, as to the validity of the Ordinary Shares                                                                                                              |
| 5.2*    |     | Opinion of Greenberg Traurig, LLP                                                                                                                                                                                                               |
| 10.1*+  |     | Regentis Biomaterials Ltd. 2009 Share In